Lv12
10 积分 2022-08-31 加入
TUB-040, a homogenous and hydrophilic NaPi2b-targeting ADC with stably linked exatecan, exhibits long-lasting anti-tumor activity and a well-tolerated safety profile
8小时前
待确认
Discovery and Preclinical Evaluation of PBX-7016, a Methylenedioxy-Camptothecin Payload for Antibody-Drug Conjugates with Enhanced Therapeutic Potential
1天前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
8天前
已完结
New Potent Sulfonamide-Based Inhibitors of S. aureus Biotin Protein Ligase
2个月前
已完结
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial Agents
2个月前
已完结
Site-Specific Bioconjugation Using SMARTag® Technology: A Practical and Effective Chemoenzymatic Approach to Generate Antibody–Drug Conjugates
2个月前
已完结
Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma
2个月前
已完结
Elements of cancer immunity and the cancer–immune set point
2个月前
已完结
MET is required for the recruitment of anti-tumoural neutrophils
2个月前
已完结
Reprogramming the tumor microenvironment: synergistic mechanisms of antibody–drug conjugates and immune checkpoint inhibitors
2个月前
已完结
皖公网安备34019202002308
